Alembic unloads Baddi formulation plant for undisclosed sum

India's Alembic Pharmaceuticals is selling one of its manufacturing plants.

Alembic Pharmaceuticals, an India-based API maker, is selling its formulation manufacturing plant in Baddi to Scott Edil Pharmacia for an undisclosed amount, according to a filing (PDF) with the Bombay Stock Exchange.

No financial details of the deal, which Alembic said in the filing is on a “slump sale basis,” were disclosed. Alembic noted that the turnover and net worth of the plant over the last financial year was “insignificant.”

The company said it will continue to meet its domestic formulation demand from its facility in Sikkim, and its Panelav unit will continue meet international formulation demand.


Veeva 2020 Unified Clinical Operations Survey

We believe you have the knowledge and expertise to make this year's Veeva 2020 Clinical Operations Report even more robust and insightful than the last. Please take a moment to share your opinion in this 10-minute survey. All qualified respondents will be entered to win a $500 Amazon gift card.

Notice of the sale comes just days after Alembic reported that a fire last week disrupted production at a generics plant it operates as part of a joint venture in Algeria. 

Alembic, which is best known for manufacturing anti-infective, analgesic and cough and cold therapies, last month announced it would enter the oncology drug market by opening an anticancer manufacturing facility at Panelav, Halol, in Gujarat. That plant is expected to produce 60 million tablets and capsules and about 20 million vials of liquid injectable and lyophilized concentrates.

Suggested Articles

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

As flights from China contract and prices double, the logistics of getting products out of China is a major challenge. 

A group of drugmakers and others say some federal policies to fight COVID-19 are it making more expensive and harder to get some drugs.